Skip to main content

Cystinuria clinical trials at UCSF
1 research study open to eligible people

  • Lipoic Acid Supplement for Cystine Stone

    open to eligible people ages 18 years and up

    This study evaluates how daily alpha lipoic acid supplementation affects cystine kidney stone recurrence. Half of the subjects will receive 1200 mg alpha lipoic acid orally daily for three years, while the other half will receive a placebo. The funding source for this clinical trial is FDA OOPD.

    San Francisco, California

Last updated: